SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001628280-17-005098
Filing Date
2017-05-08
Accepted
2017-05-08 08:50:54
Documents
2
Period of Report
2017-05-08
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a8k080517.htm 8-K 29053
2 EXHIBIT 99.1 exhibit991.htm EX-99.1 12187
  Complete submission text file 0001628280-17-005098.txt   42442
Mailing Address 420 LEXINGTON AVENUE 25TH FLOOR NEW YORK NY 10170
Business Address 420 LEXINGTON AVENUE 25TH FLOOR NEW YORK NY 10170 212-398-4627
Rasna Therapeutics Inc. (Filer) CIK: 0001582249 (see all company filings)

IRS No.: 392080103 | State of Incorp.: NV | Fiscal Year End: 0630
Type: 8-K | Act: 34 | File No.: 333-191083 | Film No.: 17820707
SIC: 2834 Pharmaceutical Preparations